• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Eleanor ncRNAs 通过激活 ESR1 基因座的拓扑结构域来平衡细胞凋亡。

The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis.

机构信息

Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, 860-0811, Japan.

Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, 41522, Egypt.

出版信息

Nat Commun. 2019 Aug 22;10(1):3778. doi: 10.1038/s41467-019-11378-4.

DOI:10.1038/s41467-019-11378-4
PMID:31439835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6706407/
Abstract

MCF7 cells acquire estrogen-independent proliferation after long-term estrogen deprivation (LTED), which recapitulates endocrine therapy resistance. LTED cells can become primed for apoptosis, but the underlying mechanism is largely unknown. We previously reported that Eleanor non-coding RNAs (ncRNAs) upregulate the ESR1 gene in LTED cells. Here, we show that Eleanors delineate the topologically associating domain (TAD) of the ESR1 locus in the active nuclear compartment of LTED cells. The TAD interacts with another transcriptionally active TAD, which is 42.9 Mb away from ESR1 and contains a gene encoding the apoptotic transcription factor FOXO3. Inhibition of a promoter-associated Eleanor suppresses all genes inside the Eleanor TAD and the long-range interaction between the two TADs, but keeps FOXO3 active to facilitate apoptosis in LTED cells. These data indicate a role of ncRNAs in chromatin domain regulation, which may underlie the apoptosis-prone nature of therapy-resistant breast cancer cells and could be good therapeutic targets.

摘要

MCF7 细胞在长期去雌激素剥夺(LTED)后获得雌激素非依赖性增殖,从而重现内分泌治疗耐药性。LTED 细胞可以被诱导凋亡,但潜在的机制在很大程度上尚不清楚。我们之前报道过 Eleanor 非编码 RNA(ncRNA)上调 LTED 细胞中的 ESR1 基因。在这里,我们表明 Eleanor 划定了 LTED 细胞中 ESR1 基因座的拓扑关联结构域(TAD)。该 TAD 与另一个转录活性的 TAD 相互作用,该 TAD 距离 ESR1 有 42.9Mb 远,包含编码凋亡转录因子 FOXO3 的基因。与启动子相关的 Eleanor 的抑制作用抑制了 Eleanor TAD 内的所有基因和两个 TAD 之间的长程相互作用,但保持 FOXO3 活性以促进 LTED 细胞凋亡。这些数据表明 ncRNA 在染色质结构域调节中起作用,这可能是治疗耐药性乳腺癌细胞易凋亡的基础,并且可能是良好的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/3642d02d8551/41467_2019_11378_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/25316fecf20e/41467_2019_11378_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/5a16cf9f2660/41467_2019_11378_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/128772894b92/41467_2019_11378_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/4c5a2c47d5a3/41467_2019_11378_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/8c7295ed0671/41467_2019_11378_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/3b49127dc9ba/41467_2019_11378_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/3642d02d8551/41467_2019_11378_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/25316fecf20e/41467_2019_11378_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/5a16cf9f2660/41467_2019_11378_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/128772894b92/41467_2019_11378_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/4c5a2c47d5a3/41467_2019_11378_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/8c7295ed0671/41467_2019_11378_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/3b49127dc9ba/41467_2019_11378_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b13/6706407/3642d02d8551/41467_2019_11378_Fig7_HTML.jpg

相似文献

1
The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis.Eleanor ncRNAs 通过激活 ESR1 基因座的拓扑结构域来平衡细胞凋亡。
Nat Commun. 2019 Aug 22;10(1):3778. doi: 10.1038/s41467-019-11378-4.
2
Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.大豆苷元 I 通过 Eleanor 非编码 RNA 抑制内分泌治疗耐药乳腺癌模型细胞。
Sci Rep. 2018 Oct 12;8(1):15202. doi: 10.1038/s41598-018-33227-y.
3
A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.一组非编码RNA在乳腺癌适应过程中激活ESR1基因座。
Nat Commun. 2015 Apr 29;6:6966. doi: 10.1038/ncomms7966.
4
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.胆固醇生物合成途径作为雌激素受体阳性乳腺癌中对雌激素剥夺耐药的一种新机制。
Breast Cancer Res. 2016 Jun 1;18(1):58. doi: 10.1186/s13058-016-0713-5.
5
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.鉴定趋化因子受体作为雌激素受体阳性乳腺癌内分泌抵抗的潜在调节因子。
Breast Cancer Res. 2014 Oct 31;16(5):447. doi: 10.1186/s13058-014-0447-1.
6
Nucleosome destabilization by nuclear non-coding RNAs.核非编码 RNA 导致核小体不稳定。
Commun Biol. 2020 Feb 11;3(1):60. doi: 10.1038/s42003-020-0784-9.
7
SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.SGK3通过维持内质网稳态来维持雌激素受体α信号传导并驱动获得性芳香化酶抑制剂耐药性。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1500-E1508. doi: 10.1073/pnas.1612991114. Epub 2017 Feb 7.
8
Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.三重阻断 mTORC1、表皮生长因子和雌激素受体信号通路靶向治疗内分泌耐药乳腺癌的肿瘤重编程。
Breast Cancer Res. 2018 Jun 8;20(1):44. doi: 10.1186/s13058-018-0983-1.
9
Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells.芳香酶抑制剂耐药乳腺癌细胞中增强的外泌体产生的证据。
Int J Mol Sci. 2020 Aug 14;21(16):5841. doi: 10.3390/ijms21165841.
10
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.响应特定内分泌疗法的差异性表观遗传重编程促进胆固醇生物合成和细胞侵袭。
Nat Commun. 2015 Nov 27;6:10044. doi: 10.1038/ncomms10044.

引用本文的文献

1
Insights into the Molecular Mechanisms of Bushen Huoxue Decoction in Breast Cancer Network Pharmacology and experiments.补肾活血汤治疗乳腺癌分子机制的研究:网络药理学与实验
Curr Comput Aided Drug Des. 2025;21(1):50-66. doi: 10.2174/0115734099269728231115060827.
2
3C methods in cancer research: recent advances and future prospects.3C 方法在癌症研究中的应用:最新进展与未来展望。
Exp Mol Med. 2024 Apr;56(4):788-798. doi: 10.1038/s12276-024-01236-9. Epub 2024 Apr 25.
3
Topologically associating domain underlies tissue specific expression of long intergenic non-coding RNAs.

本文引用的文献

1
Non-coding RNAs and chromatin domains.非编码 RNA 与染色质域。
Curr Opin Cell Biol. 2019 Jun;58:26-33. doi: 10.1016/j.ceb.2018.12.005. Epub 2019 Jan 23.
2
Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.大豆苷元 I 通过 Eleanor 非编码 RNA 抑制内分泌治疗耐药乳腺癌模型细胞。
Sci Rep. 2018 Oct 12;8(1):15202. doi: 10.1038/s41598-018-33227-y.
3
The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions.
拓扑相关结构域是长基因间非编码RNA组织特异性表达的基础。
iScience. 2023 Apr 26;26(5):106640. doi: 10.1016/j.isci.2023.106640. eCollection 2023 May 19.
4
Mechanisms of Long Non-Coding RNA in Breast Cancer.长链非编码 RNA 在乳腺癌中的作用机制。
Int J Mol Sci. 2023 Feb 25;24(5):4538. doi: 10.3390/ijms24054538.
5
Estrogen-Inducible LncRNA Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells.雌激素诱导的长非编码 RNA 作为内分泌抵抗型乳腺癌细胞中雌激素受体信号的调节剂。
Cells. 2022 Nov 15;11(22):3610. doi: 10.3390/cells11223610.
6
Micellization: A new principle in the formation of biomolecular condensates.胶束化:生物分子凝聚物形成的新原理。
Front Mol Biosci. 2022 Aug 29;9:974772. doi: 10.3389/fmolb.2022.974772. eCollection 2022.
7
Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes.乳腺癌休眠:自噬、lncRNAs、miRNAs 和外泌体的作用。
Int J Mol Sci. 2022 May 9;23(9):5271. doi: 10.3390/ijms23095271.
8
3D chromatin architecture and transcription regulation in cancer.癌症中的 3D 染色质结构和转录调控。
J Hematol Oncol. 2022 May 4;15(1):49. doi: 10.1186/s13045-022-01271-x.
9
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.ELEANOR 非编码 RNA 表达促进癌症休眠并预测雌激素受体阳性乳腺癌的晚期复发。
Cancer Sci. 2022 Jul;113(7):2336-2351. doi: 10.1111/cas.15373. Epub 2022 May 3.
10
The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol.酮体在结肠上皮细胞中的变构作用是由微管过度乙酰化介导的,并且可以被白藜芦醇所阻断。
Int J Mol Sci. 2021 Aug 30;22(17):9397. doi: 10.3390/ijms22179397.
3D 基因组浏览器:一个用于可视化 3D 基因组组织和长距离染色质相互作用的基于网络的浏览器。
Genome Biol. 2018 Oct 4;19(1):151. doi: 10.1186/s13059-018-1519-9.
4
Practical Analysis of Hi-C Data: Generating A/B Compartment Profiles.Hi-C数据的实践分析:生成A/B区室图谱。
Methods Mol Biol. 2018;1861:221-245. doi: 10.1007/978-1-4939-8766-5_16.
5
HiCcompare: an R-package for joint normalization and comparison of HI-C datasets.HiCcompare:用于 Hi-C 数据集联合标准化和比较的 R 包。
BMC Bioinformatics. 2018 Jul 31;19(1):279. doi: 10.1186/s12859-018-2288-x.
6
Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs.Srf 通过抑制细胞类型特异性基因表达程序来破坏细胞身份。
Nat Commun. 2018 Apr 11;9(1):1387. doi: 10.1038/s41467-018-03748-1.
7
Genomic positional conservation identifies topological anchor point RNAs linked to developmental loci.基因组位置保守性鉴定与发育基因座相关的拓扑锚定 RNA。
Genome Biol. 2018 Mar 15;19(1):32. doi: 10.1186/s13059-018-1405-5.
8
Therapeutic Targeting of Long Non-Coding RNAs in Cancer.癌症中长链非编码 RNA 的治疗靶向。
Trends Mol Med. 2018 Mar;24(3):257-277. doi: 10.1016/j.molmed.2018.01.001. Epub 2018 Feb 12.
9
Two independent modes of chromatin organization revealed by cohesin removal.通过去除黏连蛋白揭示的两种独立的染色质组织模式。
Nature. 2017 Nov 2;551(7678):51-56. doi: 10.1038/nature24281. Epub 2017 Sep 27.
10
Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.非编码转录指导染色质折叠和区室化以决定增强子-启动子通讯及T细胞命运。
Cell. 2017 Sep 21;171(1):103-119.e18. doi: 10.1016/j.cell.2017.09.001.